FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frank Schlichtenbrede

Research Profile

Disorders

Living Beings

Procedures

Anatomy

Chemicals & Drugs

Physiology

Visual Acuity

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Björn C Harder; Bettina Jendritza; Waldemar Jendritza; Frank C Schlichtenbrede; Stefan von Baltz; Jost B Jonas
Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.
Bjoern C Harder; Frank C Schlichtenbrede; Stefan von Baltz; Jost B Jonas
Early refractive outcome after intravitreous bevacizumab for retinopathy of prematurity.
Jost B Jonas; Yong Tao; Frank C Schlichtenbrede
Intravitreal bevacizumab for exudative age-related macular degeneration in clinical practice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frank Schlichtenbrede (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Björn C Harder; Bettina Jendritza; Waldemar Jendritza; Frank C Schlichtenbrede; Stefan von Baltz; Jost B Jonas
Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.
American journal of ophthalmology 2013;155(6):1119-1124.e1.
2012: Bjoern C Harder; Frank C Schlichtenbrede; Stefan von Baltz; Jost B Jonas
Early refractive outcome after intravitreous bevacizumab for retinopathy of prematurity.
Archives of ophthalmology 2012;130(6):800-1.
2011: Jost B Jonas; Yong Tao; Frank C Schlichtenbrede
Intravitreal bevacizumab for exudative age-related macular degeneration in clinical practice.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2011;27(5):467-70.
2011: Jost B Jonas; Alexander Decker; Barbara Mangler; Frank C Schlichtenbrede
Macular holes and central retinal detachment.
Acta ophthalmologica 2011;89(4):e377-8.
2010: Jost B Jonas; Barbara Mangler; Alexander Decker; Frank C Schlichtenbrede
Retinal re-detachment after scleral buckling procedure.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2010;248(12):1841-3.
2010: Florian Rensch; Frank C Schlichtenbrede; Jost B Jonas
Postoperative mycotic endophthalmitis.
Journal of cataract and refractive surgery 2010;36(7):1233-4.
2009: Frank C Schlichtenbrede; Wolfgang Mittmann; Florian Rensch; Franziska Vom Hagen; Jost B Jonas; Thomas Euler
Toxicity assessment of intravitreal triamcinolone and bevacizumab in a retinal explant mouse model using two-photon microscopy.
Investigative ophthalmology & visual science 2009;50(12):5880-7.
2009: Frank C Schlichtenbrede; Ulrich H M Spandau; Björn Harder; Jost B Jonas
Lens capsular bag irrigation for low-grade endophthalmitis.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2009;247(9):1273-6.
2006: Prateek K Buch; Robert MacLaren; Yanaí Durán; Kamaljit S Balaggan; Angus MacNeil; Frank C Schlichtenbrede; Alexander J Smith; Robin R Ali
In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(5):700-9.
2005: Marion Tschernutter; Frank C Schlichtenbrede; Steven J Howe; Kamaljit S Balaggan; Peter M G Munro; J W B Bainbridge; Adrian J Thrasher; Alexander J Smith; Robin R Ali
Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy.
Gene therapy 2005;12(8):694-701.
2005: Gian-Marco Sarra; F G Sarra; Frank C Schlichtenbrede; Peter Trittibach; S Estermann; E Tsiroukis; Robin R Ali; Philip J Luthert; Martin B Reichel
Effect of steroidal and non-steroidal drugs on the microglia activation pattern and the course of degeneration in the retinal degeneration slow mouse.
Ophthalmic research 2005;37(2):72-82.
2004: Edward H Hughes; Frank C Schlichtenbrede; Conor C Murphy; Cathryn Broderick; Nico van Rooijen; Robin R Ali; Andrew D Dick
Minocycline delays photoreceptor death in the rds mouse through a microglia-independent mechanism.
Experimental eye research 2004;78(6):1077-84.
2004: Frank C Schlichtenbrede; Alexander J Smith; J W B Bainbridge; Adrian J Thrasher; Thomas E Salt; Robin R Ali
Improvement of neuronal visual responses in the superior colliculus in Prph2(Rd2/Rd2) mice following gene therapy.
Molecular and cellular neurosciences 2004;25(1):103-10.
2003: Frank C Schlichtenbrede; Lyndon da Cruz; Clare Stephens; Alexander J Smith; Anastasios Georgiadis; Adrian J Thrasher; J W B Bainbridge; Mathias W Seeliger; Robin R Ali
Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy.
The journal of gene medicine 2003;5(9):757-64.
2003: Alexander J Smith; Frank C Schlichtenbrede; Marion Tschernutter; J W B Bainbridge; Adrian J Thrasher; Robin R Ali
AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(2):188-95.
2003: J W B Bainbridge; Ajay R Mistry; Frank C Schlichtenbrede; A Smith; Cathryn Broderick; Mahesh De Alwis; Anastasios Georgiadis; Paul M Taylor; M Squires; Charanjit S Sethi; David G Charteris; Adrian J Thrasher; D Sargan; Robin R Ali
Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.
Gene therapy 2003;10(16):1336-44.
2003: Edward H Hughes; Frank C Schlichtenbrede; Conor C Murphy; Gian-Marco Sarra; Philip J Luthert; Robin R Ali; Andrew D Dick
Generation of activated sialoadhesin-positive microglia during retinal degeneration.
Investigative ophthalmology & visual science 2003;44(5):2229-34.
2003: Frank C Schlichtenbrede; Angus MacNeil; J W B Bainbridge; Marion Tschernutter; Adrian J Thrasher; Alexander J Smith; Robin R Ali
Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration.
Gene therapy 2003;10(6):523-7.
2002: Frank C Schlichtenbrede; Gian-Marco Sarra; Robin R Ali; Peter Wiedemann; Martin B Reichel
[Progress in somatic gene therapy of retinal degeneration in the animal model].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2002;99(4):259-65.
2002: Gian-Marco Sarra; Clare Stephens; Frank C Schlichtenbrede; J W B Bainbridge; Adrian J Thrasher; Philip J Luthert; Robin R Ali
Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus.
Vision research 2002;42(4):541-9.
2001: Martin B Reichel; Frank C Schlichtenbrede; D Paul; Peter Wiedemann
[Retinal degeneration. Apoptosis as pathomechanism and therapy strategy].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2001;98(3):242-7.